Anbio Biotechnology Investment Income, Interest
Anbio Biotechnology (NNNN) reported Investment Income, Interest of $142.02 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-04-07
| Period end | Investment Income, Interest 12 month |
|---|---|
| 2025-12-31 | $142.02K 20-F · filed 2026-04-07 |
| 2024-12-31 | $337.51K 20-F · filed 2026-04-07 |
| 2023-12-31 | $165.34K 20-F · filed 2026-04-07 |
| 2022-12-31 | $42.24K 20-F · filed 2025-04-28 |